Confessions of a managed behavioral health care physicianFELDMAN, Steven A.Journal of developmental and behavioral pediatrics. 2002, Vol 23, Num 1, pp S51-S56, issn 0196-206X, SUPArticle

Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen ReceptorKOCHENDERFER, James N; FELDMAN, Steven A; YANGBING ZHAO et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 7, pp 689-702, issn 1524-9557, 14 p.Article

Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivityCRIM, Roberta L; AUDET, Susette A; FELDMAN, Steven A et al.Journal of virology. 2007, Vol 81, Num 1, pp 261-271, issn 0022-538X, 11 p.Article

Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinomaWANG, Qiong J; HANADA, Ken-Ichi; FELDMAN, Steven A et al.Journal of immunological methods. 2011, Vol 366, Num 1-2, pp 43-51, issn 0022-1759, 9 p.Article

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD 19 chimeric-antigen-receptor-transduced T cellsKOCHENDERFER, James N; DUDLEY, Mark E; YANG, James C et al.Blood. 2012, Vol 119, Num 12, pp 2709-2720, issn 0006-4971, 12 p.Article

Rapid Production of Clinical-Grade Gammaretroviral Vectors in Expanded Surface Roller Bottles Using a Modified Step-Filtration Process for Clearance of Packaging CellsFELDMAN, Steven A; GOFF, Stephanie L; MORGAN, Richard A et al.Human gene therapy. 2011, Vol 22, Num 1, pp 107-115, issn 1043-0342, 9 p.Article

Augmented Lymphocyte Expansion from Solid Tumors With Engineered Cells for Costimulatory EnhancementFRIEDMAN, Kevin M; DEVILLIER, Laura E; FELDMAN, Steven A et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 9, pp 651-661, issn 1524-9557, 11 p.Article

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD 19KOCHENDERFER, James N; WILSON, Wyndham H; MORGAN, Richard A et al.Blood. 2010, Vol 116, Num 20, pp 4099-4102, issn 0006-4971, 4 p.Article

Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus bindingFELDMAN, Steven A; FARRELL, Karen B; MURTHY, Ravi K et al.Journal of virology. 2004, Vol 78, Num 2, pp 595-602, issn 0022-538X, 8 p.Article

Evaluation of γ-Retroviral Vectors That Mediate the Inducible Expression of IL-12 for Clinical ApplicationLING ZHANG; FELDMAN, Steven A; ZHILI ZHENG et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 5, pp 430-439, issn 1524-9557, 10 p.Article

Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for GliomaMORGAN, Richard A; JOHNSON, Laura A; WEI ZHANG et al.Human gene therapy. 2012, Vol 23, Num 10, pp 1043-1053, issn 1043-0342, 11 p.Article

A Simple and Effective Method to Generate Lentiviral Vectors for Ex Vivo Gene Delivery to Mature Human Peripheral Blood LymphocytesSHICHENG YANG; KARNE, Neel K; GOFF, Stephanie L et al.Human gene therapy. Part B. Methods (Print). 2012, Vol 23, Num 2, pp 73-83, issn 1946-6536, 11 p.Article

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1ROBBINS, Paul F; MORGAN, Richard A; KAMMULA, Udai S et al.Journal of clinical oncology. 2011, Vol 29, Num 7, pp 917-924, issn 0732-183X, 8 p.Article

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionGOFF, Stephanie L; JOHNSON, Laura A; BLACK, Mary A et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 10, pp 1551-1560, issn 0340-7004, 10 p.Article